These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31841386)

  • 1. IL-6
    Yang X; Yan H; Jiang N; Yu Z; Yuan J; Ni Z; Fang W
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F338-F353. PubMed ID: 31841386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3/HIF-1α signaling activation mediates peritoneal fibrosis induced by high glucose.
    Yang X; Bao M; Fang Y; Yu X; Ji J; Ding X
    J Transl Med; 2021 Jun; 19(1):283. PubMed ID: 34193173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway.
    Xiao J; Gong Y; Chen Y; Yu D; Wang X; Zhang X; Dou Y; Liu D; Cheng G; Lu S; Yuan W; Li Y; Zhao Z
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F310-F318. PubMed ID: 28490530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
    Shi Y; Li J; Chen H; Hu Y; Tang L; Wang Y; Zang X; Ma X; Huang G; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Zhuang S; Liu N
    J Pathol; 2022 Oct; 258(2):164-178. PubMed ID: 35792675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum response factor accelerates the high glucose-induced Epithelial-to-Mesenchymal Transition (EMT) via snail signaling in human peritoneal mesothelial cells.
    He L; Lou W; Ji L; Liang W; Zhou M; Xu G; Zhao L; Huang C; Li R; Wang H; Chen X; Sun S
    PLoS One; 2014; 9(10):e108593. PubMed ID: 25303231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
    Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
    Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
    Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
    Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
    Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
    Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis.
    Lho Y; Park Y; Do JY; Kim AY; Park YE; Kang SH
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F363-F372. PubMed ID: 38961839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane.
    Catar R; Witowski J; Zhu N; Lücht C; Derrac Soria A; Uceda Fernandez J; Chen L; Jones SA; Fielding CA; Rudolf A; Topley N; Dragun D; Jörres A
    J Am Soc Nephrol; 2017 Apr; 28(4):1188-1199. PubMed ID: 27837150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
    Su W; Wang H; Feng Z; Sun J
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT signaling is required for peritoneal membrane angiogenesis.
    Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3.
    Li N; Fu J; Wang Q; Rao Q; Yao L; Shao X; Zhang P
    Ren Fail; 2024 Dec; 46(2):2394635. PubMed ID: 39192609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization.
    Hu Y; Zhou C; Zhong Q; Li X; Li J; Shi Y; Ma X; Jiang D; Wang Y; Zhuang S; Liu N
    Ren Fail; 2024 Dec; 46(2):2392849. PubMed ID: 39165231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of STAT3 by S3I-201 suppress peritoneal fibroblast phenotype conversion and alleviate peritoneal fibrosis.
    Song Q; Li H; Yan H; Yu Z; Li Z; Yuan J; Jiang N; Ni Z; Gu L; Fang W
    J Cell Mol Med; 2024 May; 28(10):e18381. PubMed ID: 38780509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells.
    Shi SS; Zhang YQ; Zhang LQ; Li YF; Zhou XS; Li RS
    Int Urol Nephrol; 2024 Aug; 56(8):2659-2670. PubMed ID: 38483736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor.
    Liu J; Feng Y; Li N; Shao QY; Zhang QY; Sun C; Xu PF; Jiang CM
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F273-F284. PubMed ID: 33427062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.